Wangkaew Suparaporn, Lertthanaphok Supawita, Puntana Saowanee, Noppakun Kajohnsak
Division of Rheumatology, Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand.
Division of Nephrology, Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand.
Int J Rheum Dis. 2017 Oct;20(10):1562-1571. doi: 10.1111/1756-185X.13145. Epub 2017 Jul 27.
Data regarding the prevalence, risk factors and outcome of scleroderma renal crisis (SRC) in Asian patients with systemic sclerosis (SSc) are limited.
To determine the prevalence, risk factors and outcomes of SRC in Thai SSc patients.
Medical records of all SSc patients seen at the Division of Rheumatology, Chiang Mai University, Thailand, from January 1990 to December 2015 were retrospectively reviewed. For each SRC case, a disease duration (±1 year) matched control (four SSc patient without SRC for each SRC patient) was identified.
Of 608 SSc patients seen during the study period, 19 SRC cases were identified, resulting in an SRC prevalence of 3.13%, with 76 matched controls. Of the 19 cases, mean ± SD age and median (interquartile range 1-3) disease duration was 56.2 ± 13.8 years and 5 (3-22) months, respectively. Seventeen patients (89.5%) had diffuse cutaneous SSc. Twelve patients (63.2%) had hypertensive renal crisis and seven (36.8%) had normotensive renal crisis. Multivariate conditional logistic regression analyses showed that digital gangrene (adjusted odd ratio [AOR] 31.41, 95% CI = 1.16-852.23, P = 0.041), current prednisolone dose ≥ 15 mg/day (AOR 31.22, 95% CI = 1.59-613.85, P = 0.024), serum albumin < 3 mg/dL (AOR 7.97, 95% CI = 1.49-42.56, P = 0.015), and cardiac involvement (AOR = 6.62, 95% CI = 1.08-40.63, P = 0.041) were independent risk factors for SRC. Fifteen SRC patients (78.9%) required dialysis and 10 (52.6%) died.
SRC was an uncommon complication in Thai patients with SSc, but is associated with high mortality. Digital gangrene, current prednisolone dose ≥ 15 mg/day, serum albumin < 3 mg/dL and cardiac involvement were independent risk factors for SRC.
关于亚洲系统性硬化症(SSc)患者硬皮病肾危象(SRC)的患病率、危险因素及预后的数据有限。
确定泰国SSc患者中SRC的患病率、危险因素及预后。
回顾性分析了1990年1月至2015年12月在泰国清迈大学风湿病科就诊的所有SSc患者的病历。对于每例SRC病例,确定了疾病病程(±1年)匹配的对照(每例SRC患者对应4例无SRC的SSc患者)。
在研究期间就诊的608例SSc患者中,确诊19例SRC病例,SRC患病率为3.13%,有76例匹配对照。19例病例中,平均±标准差年龄和疾病病程中位数(四分位间距1 - 3)分别为56.2±13.8岁和5(3 - 22)个月。17例患者(89.5%)为弥漫性皮肤型SSc。12例患者(63.2%)发生高血压肾危象,7例(36.8%)发生血压正常的肾危象。多因素条件逻辑回归分析显示,指端坏疽(调整比值比[AOR] 31.41,95%置信区间 = 1.16 - 852.23,P = 0.041)、当前泼尼松龙剂量≥15 mg/天(AOR 31.22,95%置信区间 = 1.59 - 613.85,P = 0.024)、血清白蛋白<3 mg/dL(AOR 7.97,95%置信区间 = 1.49 - 42.56,P = 0.015)以及心脏受累(AOR = 6.62,95%置信区间 = 1.08 - 40.63,P = 0.041)是SRC的独立危险因素。15例SRC患者(78.9%)需要透析,10例(52.6%)死亡。
SRC在泰国SSc患者中是一种罕见的并发症,但与高死亡率相关。指端坏疽、当前泼尼松龙剂量≥15 mg/天、血清白蛋白<3 mg/dL以及心脏受累是SRC的独立危险因素。